The pros, cons, and many unknowns of probiotics

[1]  S. Allen,et al.  Probiotics for treating acute infectious diarrhoea , 2010, The Cochrane database of systematic reviews.

[2]  N. Zmora,et al.  Probiotics in the next-generation sequencing era , 2019, Gut microbes.

[3]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[4]  A. Pierro.  Faculty Opinions recommendation of The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[5]  T. Hansen,et al.  The antidepressant-like effect of probiotics and their faecal abundance may be modulated by the cohabiting gut microbiota in rats , 2019, European Neuropsychopharmacology.

[6]  J. Linder,et al.  Does probiotic consumption reduce antibiotic utilization for common acute infections? A systematic review and meta-analysis , 2018, European journal of public health.

[7]  Martha L. Carvour,et al.  Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital‐wide cohort , 2019, American journal of infection control.

[8]  E. Goldstein,et al.  Choosing an appropriate probiotic product for your patient: An evidence-based practical guide , 2018, PloS one.

[9]  Cody S. Olsen,et al.  Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children , 2018, The New England journal of medicine.

[10]  K. Farion,et al.  Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis , 2018, The New England journal of medicine.

[11]  William H. Bisson,et al.  Gut microbiota and intestinal FXR mediate the clinical benefits of metformin , 2018, Nature Medicine.

[12]  Qingya Liu,et al.  The Probiotic Effectiveness in Preventing Experimental Colitis Is Correlated With Host Gut Microbiota , 2018, Front. Microbiol..

[13]  Markku Varjosalo,et al.  Probiotic supplementation restores normal microbiota composition and function in antibiotic-treated and in caesarean-born infants , 2018, Microbiome.

[14]  P. Moayyedi,et al.  Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome , 2018, Alimentary pharmacology & therapeutics.

[15]  G. Suen,et al.  Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection , 2018, PloS one.

[16]  Jop de Vrieze.  The metawars. , 2018, Science.

[17]  Itai Sharon,et al.  Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT , 2018, Cell.

[18]  Itai Sharon,et al.  Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features , 2018, Cell.

[19]  G. Widmer,et al.  Probiotic Product Enhances Susceptibility of Mice to Cryptosporidiosis , 2018, Applied and Environmental Microbiology.

[20]  M. Boaz,et al.  The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea‐predominant irritable bowel syndrome , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  N. Iwabuchi,et al.  Effects of paraprobiotic Lactobacillus paracasei MCC1849 supplementation on symptoms of the common cold and mood states in healthy adults. , 2018, Beneficial microbes.

[22]  P. Ravaud,et al.  Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota , 2018, Annals of Internal Medicine.

[23]  N. Speybroeck,et al.  Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 8: suitability of taxonomic units notified to EFSA until March 2018 , 2018, EFSA journal. European Food Safety Authority.

[24]  Luke R. Thompson,et al.  Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.

[25]  S. Ilardi,et al.  The anxiolytic effect of probiotics: A systematic review and meta-analysis of the clinical and preclinical literature , 2018, PloS one.

[26]  T. Ushiki,et al.  A bacterial metabolite ameliorates periodontal pathogen-induced gingival epithelial barrier disruption via GPR40 signaling , 2018, Scientific Reports.

[27]  S. Gill,et al.  Probiotic supplementation and associated infant gut microbiome and health: a cautionary retrospective clinical comparison , 2018, Scientific Reports.

[28]  Weston R. Whitaker,et al.  An exclusive metabolic niche enables strain engraftment in the gut microbiota , 2018, Nature.

[29]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[30]  P. Langella,et al.  Opposing effect of Lactobacillus on in vitro Klebsiella pneumoniae in biofilm and in an in vivo intestinal colonisation model. , 2017, Beneficial microbes.

[31]  C. Vandelanotte,et al.  A review of probiotic supplementation in healthy adults: helpful or hype? , 2018, European Journal of Clinical Nutrition.

[32]  P. Brigidi,et al.  An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults , 2017, PloS one.

[33]  S. Yakout,et al.  Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial , 2017, Journal of Translational Medicine.

[34]  A. Ford,et al.  Use of Probiotics in Hospitalized Adults to Prevent Clostridium difficile Infection: DownGRADE the Quality of Evidence? , 2017, Gastroenterology.

[35]  T. van de Wiele,et al.  Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications , 2017, Front. Microbiol..

[36]  U. Sauer,et al.  Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response , 2018, Immunity.

[37]  N. Paneth,et al.  A randomized synbiotic trial to prevent sepsis among infants in rural India , 2017, Nature.

[38]  Xue-Ru Wu,et al.  Uromodulin–SlpA binding dictates Lactobacillus acidophilus uptake by intestinal epithelial M cells , 2017, International immunology.

[39]  Q. Zou,et al.  Effects of anti-Helicobacter pylori concomitant therapy and probiotic supplementation on the throat and gut microbiota in humans. , 2017, Microbial pathogenesis.

[40]  L. Morelli,et al.  Probiotics Prevent Late-Onset Sepsis in Human Milk-Fed, Very Low Birth Weight Preterm Infants: Systematic Review and Meta-Analysis , 2017, Nutrients.

[41]  Moez Sanaa,et al.  Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017 , 2017, EFSA journal. European Food Safety Authority.

[42]  N. Larsson,et al.  Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic‐Associated Gastrointestinal Symptoms in Children—Randomized, Double‐Blind, Placebo‐Controlled Study , 2017, The Journal of pediatrics.

[43]  J. Raes,et al.  The resilience of the intestinal microbiota influences health and disease , 2017, Nature Reviews Microbiology.

[44]  J. Parsonnet,et al.  Probiotic guidelines and physician practice: a cross-sectional survey and overview of the literature. , 2017, Beneficial microbes.

[45]  A. Evans,et al.  Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis. , 2017, Gastroenterology.

[46]  J. Drai,et al.  Probiotic yogurt and acidified milk similarly reduce postprandial inflammation and both alter the gut microbiota of healthy, young men. , 2017, The British journal of nutrition.

[47]  Takuya Suzuki,et al.  Supplemental feeding of a gut microbial metabolite of linoleic acid, 10-hydroxy-cis-12-octadecenoic acid, alleviates spontaneous atopic dermatitis and modulates intestinal microbiota in NC/nga mice , 2017, International journal of food sciences and nutrition.

[48]  G. Boylan,et al.  Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects , 2017, Brain, Behavior, and Immunity.

[49]  Xiaohui Gong,et al.  The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants , 2017, Neonatology.

[50]  S. Dowd,et al.  Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers , 2016, Gut microbes.

[51]  M. Washington,et al.  Neonatal Colonization of Mice with LGG Promotes Intestinal Development and Decreases Susceptibility to Colitis in Adulthood , 2016, Mucosal Immunology.

[52]  Jennifer Beardsley,et al.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. , 2017, The Cochrane database of systematic reviews.

[53]  H. Smidt,et al.  Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial , 2016, PloS one.

[54]  I. Amit,et al.  Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations , 2016, Cell.

[55]  T. Vatanen,et al.  The effect of host genetics on the gut microbiome , 2016, Nature Genetics.

[56]  T. Dinan,et al.  Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals , 2016, Trends in Neurosciences.

[57]  Benjamin M Hillmann,et al.  Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. , 2016, Cell host & microbe.

[58]  Jiaqi Deng,et al.  Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.

[59]  C. Akdis,et al.  The Surface-Associated Exopolysaccharide of Bifidobacterium longum 35624 Plays an Essential Role in Dampening Host Proinflammatory Responses and Repressing Local TH17 Responses , 2016, Applied and Environmental Microbiology.

[60]  M. Lomer,et al.  British Dietetic Association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). , 2016, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[61]  D. Fuchs,et al.  Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis , 2016, Alimentary pharmacology & therapeutics.

[62]  T. Savidge,et al.  Administration of probiotic kefir to mice with Clostridium difficile infection exacerbates disease. , 2016, Anaerobe.

[63]  Gonzalo Viana Di Prisco,et al.  Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring , 2016, Cell.

[64]  Oluf Pedersen,et al.  Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials , 2016, Genome Medicine.

[65]  J. Speakman,et al.  Probiotics Reduce the Risk of Antibiotic-Associated Diarrhea in Adults (18-64 Years) but Not the Elderly (>65 Years): A Meta-Analysis. , 2016, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[66]  Chao Lu,et al.  Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis , 2016, Scientific Reports.

[67]  Johan E T van Hylckama Vlieg,et al.  Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes , 2016, The ISME Journal.

[68]  David C. Gondek,et al.  Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice , 2016, Gut microbes.

[69]  M. Kano,et al.  Living cells of probiotic Bifidobacterium bifidum YIT 10347 detected on gastric mucosa in humans. , 2016, Beneficial microbes.

[70]  H. Szajewska,et al.  Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. , 2016, Journal of pediatric gastroenterology and nutrition.

[71]  S. Patole,et al.  Probiotic Supplementation and Late-Onset Sepsis in Preterm Infants: A Meta-analysis , 2016, Pediatrics.

[72]  K. Costeloe,et al.  Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial , 2016, The Lancet.

[73]  Shristi Shakya,et al.  Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates , 2016, Medicine.

[74]  C. Cooper,et al.  Lactobacillus Sepsis following a Laparotomy in a Preterm Infant: A Note of Caution , 2016, Neonatology.

[75]  S. Mazmanian,et al.  Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.

[76]  I. Amit,et al.  Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations , 2016, Cell.

[77]  G. Greisen,et al.  Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies , 2015, Neonatology.

[78]  T. Pieber,et al.  Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study , 2015, PloS one.

[79]  Y. Yamashiro,et al.  Intestinal Microbiota Profiles of Healthy Pre-School and School-Age Children and Effects of Probiotic Supplementation , 2015, Annals of Nutrition and Metabolism.

[80]  M. Mochizuki,et al.  Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic Individuals , 2015, PloS one.

[81]  M. Hattori,et al.  Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells , 2015, Cell.

[82]  N. Usheva,et al.  USE OF THE PROBIOTIC Lactobacillus reuteri DSM 17938 IN THE PREVENTION OF ANTIBIOTIC-ASSOCIATED INFECTIONS IN HOSPITALIZED BULGARIAN CHILDREN: A RANDOMIZED, CONTROLLED TRIAL , 2015 .

[83]  H. Szajewska,et al.  Systematic review with meta‐analysis: Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea , 2015, Alimentary pharmacology & therapeutics.

[84]  L. Janssen,et al.  The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938 , 2015, The Journal of physiology.

[85]  S. Topçuoğlu,et al.  A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[86]  F. Darvishian,et al.  A Note of Caution , 2015, International journal of surgical pathology.

[87]  E. Le Chatelier,et al.  Dietary modulation of the gut microbiota – a randomised controlled trial in obese postmenopausal women , 2015, British Journal of Nutrition.

[88]  J. Holst,et al.  Intake of Lactobacillus reuteri Improves Incretin and Insulin Secretion in Glucose-Tolerant Humans: A Proof of Concept , 2015, Diabetes Care.

[89]  L. Hartling,et al.  Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis , 2015, PloS one.

[90]  R. Zijlstra,et al.  Feed Fermentation with Reuteran- and Levan-Producing Lactobacillus reuteri Reduces Colonization of Weanling Pigs by Enterotoxigenic Escherichia coli , 2015, Applied and Environmental Microbiology.

[91]  C. Fraser,et al.  Functional Dynamics of the Gut Microbiome in Elderly People during Probiotic Consumption , 2015, mBio.

[92]  C. Ubeda,et al.  Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. , 2015, Cell reports.

[93]  P. Barnes,et al.  Trends in the use of complementary health approaches among adults: United States, 2002-2012. , 2015, National health statistics reports.

[94]  Taixiang Wu,et al.  Probiotics for preventing acute upper respiratory tract infections , 2015, The Cochrane database of systematic reviews.

[95]  Mcfarland Lv.  Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections. , 2015 .

[96]  Takuya Suzuki,et al.  A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway* , 2014, The Journal of Biological Chemistry.

[97]  C. Dietrich,et al.  Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. , 2014, World journal of gastroenterology.

[98]  I. De Noni,et al.  Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. , 2014, The Journal of nutrition.

[99]  S. Kennedy,et al.  Changes of the human gut microbiome induced by a fermented milk product , 2014, Scientific Reports.

[100]  M. Butel,et al.  Bifidobacterium longum and Bifidobacterium breve isolates from preterm and full term neonates: comparison of cell surface properties. , 2014, Anaerobe.

[101]  M. Griffiths,et al.  Lactobacillus acidophilus modulates the virulence of Clostridium difficile. , 2014, Journal of dairy science.

[102]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[103]  Lynne V McFarland,et al.  Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review , 2014, BMJ Open.

[104]  G. M. Allan,et al.  Funding May Influence Trial Results Examining Probiotics and Clostridium difficile Diarrhea Rates , 2014, The American Journal of Gastroenterology.

[105]  V. Akbari,et al.  Efficacy and Safety of Saccharomyces boulardii for Acute Diarrhea , 2014, Pediatrics.

[106]  A. Neish,et al.  Epithelial Adhesion Mediated by Pilin SpaC Is Required for Lactobacillus rhamnosus GG-Induced Cellular Responses , 2014, Applied and Environmental Microbiology.

[107]  C. Hill,et al.  Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut , 2014, Proceedings of the National Academy of Sciences.

[108]  A. Moschetta,et al.  Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. , 2014, Cell reports.

[109]  H. Szajewska,et al.  Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. , 2014, Journal of pediatric gastroenterology and nutrition.

[110]  L. Morelli,et al.  Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial , 2014, PloS one.

[111]  S. Nikfar,et al.  A systematic review of the safety of probiotics , 2014, Expert opinion on drug safety.

[112]  L. Miller,et al.  Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study. , 2014, Vaccine.

[113]  C. Fraser,et al.  Probiotics: achieving a better regulatory fit. , 2014, Food and drug law journal.

[114]  Fei Liu,et al.  Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. , 2013, Beneficial microbes.

[115]  R. Parks,et al.  Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v , 2013, European journal of gastroenterology & hepatology.

[116]  Michael B Gravenor,et al.  Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial , 2013, The Lancet.

[117]  A. Fodor,et al.  VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer , 2013, Scientific Reports.

[118]  M. Fischbach,et al.  A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice , 2013, The ISME Journal.

[119]  J. Söderholm,et al.  The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis , 2013, Alimentary pharmacology & therapeutics.

[120]  H. Szajewska,et al.  Meta‐analysis: Lactobacillus GG for treating acute gastroenteritis in children – updated analysis of randomised controlled trials , 2013, Alimentary pharmacology & therapeutics.

[121]  M. Delledonne,et al.  Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium–host interactions , 2013, Proceedings of the National Academy of Sciences.

[122]  G. Guyatt,et al.  Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. , 2013, The Cochrane database of systematic reviews.

[123]  W. D. de Vos,et al.  Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG , 2013, PloS one.

[124]  E. Quigley,et al.  Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic , 2013, Gut microbes.

[125]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[126]  S. Rautava,et al.  Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[127]  F. Degnan.  Clinical studies involving probiotics , 2012, Gut microbes.

[128]  R. Touger-Decker,et al.  Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections , 2012, British Journal of Nutrition.

[129]  J. Walter,et al.  Comparison of the Colonization Ability of Autochthonous and Allochthonous Strains of Lactobacilli in the Human Gastrointestinal Tract , 2012 .

[130]  Y. Fujiwara,et al.  Immunoprotective effects of oral intake of heat-killed Lactobacillus pentosus strain b240 in elderly adults: a randomised, double-blind, placebo-controlled trial , 2012, British Journal of Nutrition.

[131]  David A. Relman,et al.  Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota , 2012, Cell.

[132]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[133]  M. Claesson,et al.  Effect of Lactobacillus salivarius Bacteriocin Abp118 on the Mouse and Pig Intestinal Microbiota , 2012, PloS one.

[134]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[135]  C. Akdis,et al.  Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells , 2011, Gut.

[136]  Bernard Henrissat,et al.  The Impact of a Consortium of Fermented Milk Strains on the Gut Microbiome of Gnotobiotic Mice and Monozygotic Twins , 2011, Science Translational Medicine.

[137]  John F. Cryan,et al.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.

[138]  Philippe Marteau,et al.  Health benefits and health claims of probiotics: bridging science and marketing , 2011, British Journal of Nutrition.

[139]  T. Zeller,et al.  Summary of NICE guidance , 2011, Heart.

[140]  Michael J. Miller,et al.  Lactobacillus Adhesion to Mucus , 2011, Nutrients.

[141]  D. Pyne,et al.  Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes , 2011, Nutrition journal.

[142]  C. Grangette,et al.  Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide , 2011, Gut.

[143]  P. Shekelle,et al.  Safety of Probiotics to Reduce Risk and Prevent or Treat Disease , 2011 .

[144]  J. McCormick,et al.  Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci , 2011, Proceedings of the National Academy of Sciences.

[145]  M. Hattori,et al.  Bifidobacteria can protect from enteropathogenic infection through production of acetate , 2011, Nature.

[146]  A. Fodor,et al.  Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS‐induced colitis , 2011, Inflammatory bowel diseases.

[147]  A. Young,et al.  Persistence of Lactobacillus Reuteri DSM17938 in the Human Intestinal Tract , 2010, Journal of the American College of Nutrition.

[148]  B. Kollen,et al.  A Double-blind Randomized Controlled Trial , 2011 .

[149]  P. Shekelle,et al.  Safety of probiotics used to reduce risk and prevent or treat disease. , 2011, Evidence report/technology assessment.

[150]  T. Casale,et al.  Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. , 2010, American journal of respiratory and critical care medicine.

[151]  M. Gareau,et al.  Probiotics and the gut microbiota in intestinal health and disease , 2010, Nature Reviews Gastroenterology &Hepatology.

[152]  J. Xaus,et al.  Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. , 2010, Anaerobe.

[153]  W. MacNaughton,et al.  Probiotic bacteria and intestinal epithelial barrier function. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[154]  N. Shara,et al.  Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial , 2010, European Journal of Clinical Nutrition.

[155]  J. Versalovic,et al.  Probiotics-host communication , 2010, Gut microbes.

[156]  Anders F. Andersson,et al.  Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome , 2010, PloS one.

[157]  C. Ha,et al.  Probiotics as Therapy in Gastroenterology: A Study of Physician Opinions and Recommendations , 2010, Journal of clinical gastroenterology.

[158]  L. Miller,et al.  Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients , 2010, The American Journal of Gastroenterology.

[159]  F. Fåk,et al.  A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells , 2010, PloS one.

[160]  Marco Braga,et al.  A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. , 2010, World journal of gastroenterology.

[161]  T. Casale,et al.  A Blinded, Randomized, Controlled Trial , 2010 .

[162]  C. Sakamoto,et al.  A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. , 2009, Nutrition.

[163]  M. S. Murphy,et al.  Diarrhoea and vomiting caused by gastroenteritis in children under 5 years: summary of NICE guidance , 2009, BMJ : British Medical Journal.

[164]  Su-Ting T. Li,et al.  Parental Management of Childhood Diarrhea , 2009, Clinical pediatrics.

[165]  M. Kleerebezem,et al.  Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance , 2009, Proceedings of the National Academy of Sciences.

[166]  Matthew E Falagas,et al.  Probiotics for the prevention of respiratory tract infections: a systematic review. , 2008, International journal of antimicrobial agents.

[167]  E. Poggiogalle,et al.  Determinants of insulin resistance and nonalcoholic fatty liver disease (NAFLD) in children , 2009 .

[168]  Melanie Volkamer,et al.  Proof of Concept , 2009 .

[169]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[170]  X. Zuo,et al.  Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea‐predominant irritable bowel syndrome , 2008, Alimentary pharmacology & therapeutics.

[171]  B. Jeppsson,et al.  Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics , 2008, Acta anaesthesiologica Scandinavica.

[172]  James Versalovic,et al.  Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c‐Jun , 2008, Inflammatory bowel diseases.

[173]  Younghoon Kim,et al.  Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. , 2008, Journal of microbiology and biotechnology.

[174]  H. Szajewska,et al.  Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic‐associated diarrhoea in children , 2008, Alimentary pharmacology & therapeutics.

[175]  T. Strandberg,et al.  Bifidobacterium microbiota and parameters of immune function in elderly subjects. , 2008, FEMS immunology and medical microbiology.

[176]  R. Kekkonen,et al.  Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. , 2008, World journal of gastroenterology.

[177]  M. Boermeester,et al.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[178]  L. Saldanha.  US Food and Drug Administration regulations governing label claims for food products, including probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[179]  Elaine Holmes,et al.  Probiotic Modulation of Symbiotic Gut Microbial–host Metabolic Interactions in a Humanized Microbiome Mouse Model , 2022 .

[180]  F. Schmidt.  Meta-Analysis , 2008 .

[181]  U. Hipler,et al.  The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[182]  Fernando Baquero,et al.  Molecular analysis of yogurt containing Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus in human intestinal microbiota. , 2008, The American journal of clinical nutrition.

[183]  D. Bassler,et al.  Probiotics for prevention of necrotizing enterocolitis in preterm infants (Review) , 2014 .

[184]  B. Johnston,et al.  Probiotics for the prevention of pediatric antibiotic-associated diarrhea. , 2008, The Cochrane database of systematic reviews.

[185]  Y. Sanz,et al.  Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications , 2007, Clinical and experimental immunology.

[186]  G. Corthier,et al.  Lactobacillus rhamnosus R11 Consumed in a Food Supplement Survived Human Digestive Transit without Modifying Microbiota Equilibrium as Assessed by Real-Time Polymerase Chain Reaction , 2007, Journal of Molecular Microbiology and Biotechnology.

[187]  F. Manguso,et al.  Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations , 2007, BMJ : British Medical Journal.

[188]  O. Chassany,et al.  Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial , 2007, Alimentary pharmacology & therapeutics.

[189]  A. Palva,et al.  Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome , 2007, Alimentary pharmacology & therapeutics.

[190]  C. Bulpitt,et al.  Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.

[191]  M. Griffiths,et al.  Probiotics Affect Virulence-Related Gene Expression in Escherichia coli O157:H7 , 2007, Applied and Environmental Microbiology.

[192]  C. Hill,et al.  Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 , 2007, Proceedings of the National Academy of Sciences.

[193]  Claire Williams,et al.  Impact of consuming a milk drink containing a probiotic on mood and cognition , 2007, European Journal of Clinical Nutrition.

[194]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[195]  S. Salminen,et al.  Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile--a preliminary study. , 2007, International journal of food microbiology.

[196]  C. De Simone,et al.  The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[197]  D. Ardid,et al.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors , 2007, Nature Medicine.

[198]  S. Fujimura,et al.  Detection of Lactobacillus gasseri OLL2716 strain administered with yogurt drink in gastric mucus layer in humans , 2006, Letters in applied microbiology.

[199]  C. Koebnick,et al.  Effects of Bifidobacterium lactis Bb12 Supplementation on Intestinal Microbiota of Preterm Infants: a Double-Blind, Placebo-Controlled, Randomized Study , 2006, Journal of Clinical Microbiology.

[200]  G. Perdigón,et al.  Importance of the host specificity in the selection of probiotic bacteria. , 2006, The Journal of dairy research.

[201]  L. Mcfarland.  Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[202]  Colin Hill,et al.  Bile Salt Hydrolase Activity in Probiotics , 2006, Applied and Environmental Microbiology.

[203]  J. Doré,et al.  Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans , 2006, British Journal of Nutrition.

[204]  G. Perdigón,et al.  The Probiotic Bacterium Lactobacillus casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity , 2006, Clinical and Vaccine Immunology.

[205]  M. Kamm,et al.  Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis , 2006, Gut.

[206]  D. Jonkers,et al.  The effect of a probiotic drink with Lactobacillus plantarum 299v on the bacterial composition in faeces and mucosal biopsies of rectum and ascending colon , 2006, Alimentary pharmacology & therapeutics.

[207]  C. Cherbut,et al.  The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. , 2005, The Journal of nutrition.

[208]  R. P. Ross,et al.  Food microbiology: Bacteriocins: developing innate immunity for food , 2005, Nature Reviews Microbiology.

[209]  J. Hampe,et al.  Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. , 2005, Clinical nutrition.

[210]  H. Tsen,et al.  Antagonistic activity against Salmonella infection in vitro and in vivo for two Lactobacillus strains from swine and poultry. , 2005, International journal of food microbiology.

[211]  P. Pochart,et al.  Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. , 2005, FEMS microbiology letters.

[212]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[213]  H. Szajewska,et al.  Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea in children: a randomized double‐blind placebo‐controlled trial , 2005 .

[214]  M. Lishner,et al.  The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. , 2005, American journal of infection control.

[215]  M. Stolte,et al.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine , 2004, Gut.

[216]  N. Valeur,et al.  Colonization and Immunomodulation by Lactobacillus reuteri ATCC 55730 in the Human Gastrointestinal Tract , 2004, Applied and Environmental Microbiology.

[217]  D. Jonkers,et al.  The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo‐controlled study on the onset and duration of effects , 2003, Alimentary pharmacology & therapeutics.

[218]  M. Hollingsworth,et al.  Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro , 2003, Gut.

[219]  T. Matsuguchi,et al.  Lipoteichoic Acids from Lactobacillus Strains Elicit Strong Tumor Necrosis Factor Alpha-Inducing Activities in Macrophages through Toll-Like Receptor 2 , 2003, Clinical Diagnostic Laboratory Immunology.

[220]  D. Teitelbaum,et al.  Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model , 2002, Pediatric Surgery International.

[221]  Michelle M. Garrison,et al.  Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. , 2002, Pediatrics.

[222]  W. M. Vos,et al.  Lactobacillus paracasei subsp. paracasei F19: Survival, Ecology and Safety in the Human Intestinal Tract - A Survey of Feeding Studies within the PROBDEMO Project , 2002 .

[223]  W. M. Vos,et al.  Lactobacillus paracasei subsp. paracasei F19: Survival, Ecology and Safety in the Human Intestinal Tract-A Survey of Feeding Studies within the PROBDEMO Project , 2002 .

[224]  Y. Benno,et al.  Differences in Composition and Mucosal Adhesion of Bifidobacteria Isolated from Healthy Adults and Healthy Seniors , 2001, Current Microbiology.

[225]  B. Bassler,et al.  Quorum sensing in bacteria. , 2001, Annual review of microbiology.

[226]  R Korpela,et al.  Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial , 2001, BMJ : British Medical Journal.

[227]  A. Benini,et al.  Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone , 2001, Current Therapeutic Research.

[228]  M. de Vrese,et al.  Probiotics--compensation for lactase insufficiency. , 2001, The American journal of clinical nutrition.

[229]  T. Mattila-Sandholm,et al.  Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract , 2001 .

[230]  S. Salminen,et al.  The influence of polyunsaturated fatty acids on probiotic growth and adhesion. , 2001, FEMS microbiology letters.

[231]  H. Harmsen,et al.  Analysis of the Fecal Microflora of Human Subjects Consuming a Probiotic Product Containing Lactobacillus rhamnosusDR20 , 2000, Applied and Environmental Microbiology.

[232]  K. Michaelsen,et al.  Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans , 1999, Applied and Environmental Microbiology.

[233]  R. Satokari,et al.  Persistence of Colonization of Human Colonic Mucosa by a Probiotic Strain, Lactobacillus rhamnosusGG, after Oral Consumption , 1999, Applied and Environmental Microbiology.

[234]  S. Salminen,et al.  Probiotic bacteria down‐regulate the milk‐induced inflammatory response in milk‐hypersensitive subjects but have an immunostimulatory effect in healthy subjects , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[235]  T. Mitsuoka,et al.  Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. , 1998, International journal of food microbiology.

[236]  S. Ahrné,et al.  Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora , 1993, Applied and environmental microbiology.

[237]  P. Myllynen,et al.  A RANDOMISED CLINICAL TRIAL , 1989 .

[238]  P. Kuitunen.  EUROPEAN SOCIETY FOR PAEDIATRIC GASTROENTEROLOGY , 1974 .

[239]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.

[240]  L. Ryd,et al.  EXTENDED REPORTS Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial , 2022 .

[241]  G. A. Moore,et al.  randomised double blind placebo controlled trial , 2022 .